Intracellular distribution and regulatory function of protein phosphatases

蛋白磷酸酶的细胞内分布和调节功能

基本信息

  • 批准号:
    11480161
  • 负责人:
  • 金额:
    $ 8.38万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (B).
  • 财政年份:
    1999
  • 资助国家:
    日本
  • 起止时间:
    1999 至 2000
  • 项目状态:
    已结题

项目摘要

Among the naturally occurring inhibitors of type 1 and type 2A protein phosphatases (PP1 and PP2A), tatutomycin (TM), first isolated from the bacterium Streptomyces spiroverticillatus, is unique in that it binds to and inhibits PP1 with higher affinity than it does PP2A . The ratio of the dissociation constant for the PP1-TM interaction to that for the PP2A-TM interaction (the PP1/PP2A ratio) is in the range 0.01-0.03. No specific structural factors responsible for its characteristic affinity to the enzymes have been identified until now.In the present experiments we have evaluated the contributions of the C1-C16 segment of TM to its binding to PP1 and PP2A.According to the current binding model, this relatively hydrophobic segment, which contains a spiroketal motif with two side chains, are supposed to be accommodated in a site which is slightly apart from the catalytic center of the enzymes. We therefore expected that chemical modifications of this segment might yield some derivative … More s retaining a measurable inhibitory activity. We were also particularly interested in the fact that the enantiomeric form of the spiroketal is present in the molecule of OA, which, in contrast to TM, exhibits exceedingly higher affinity to PP2A than to PP1. Since there are numerous examples of stereospecific interaction of a macromolecule with a relatively small ligand, it seemed natural to speculate that the stereochemistry of the spiroketal might be a key factor determining the affinity characteristics of the toxins.For these reasons we have chemically synthesized two TM analogues : TM1 in which the side chains of the spiroketal is removed but its stereochemistry is retained, and TM2 in which the spiroketal motif of TM1 is replaced with its enantiomeric form. We have observed that these derivatives indeed retain considerable inhibitory activities against PP1 and PP2A.The PP1/PP2A ratio, determined by dose-inhibition analyses using the native catalytic subunits of PP1 (PP1C) and PP2A and a recombinant γ isoform of PP1(PP1γ), is in the range 0.2-0.5 with TM1 and 5-10 with TM2. The marked increases in the ratio caused by the derivatization of TM to TM1 and TM2 indicate that the stereochemistry of the spiroketal as well as the presence of its side chains is an important factor for the characteristic affinities of TM to PP1 and PP2A. Less
在1型和2A型蛋白磷酸酶(PP 1和PP 2A)的天然存在的抑制剂中,首先从细菌螺旋轮枝链霉菌(Streptomycesspiroverticillatus)中分离的达图霉素(TM)是独特的,因为它以比PP 2A更高的亲和力结合并抑制PP 1。PP 1-TM相互作用的解离常数与PP 2A-TM相互作用的解离常数之比(PP 1/PP 2A比)在0.01-0.03的范围内。本实验研究了TM的C1-C16片段对TM与PP 1和PP 2A结合的影响,根据目前的结合模型,TM的C1-C16片段是一个相对疏水的片段,含有一个螺缩酮基序和两个侧链,被认为被容纳在稍微远离酶的催化中心的位置。因此,我们预计,对这一片段进行化学修饰可能会产生一些衍生物, ...更多信息 保留可测量的抑制活性。我们还特别感兴趣的是,螺缩酮的对映体形式存在于OA分子中,与TM相反,OA对PP 2A的亲和力比对PP 1的亲和力高得多。由于存在大量的大分子与相对小的配体的立体特异性相互作用的实例,因此推测螺缩酮的立体化学可能是决定毒素的亲和特性的关键因素似乎是自然的。出于这些原因,我们化学合成了两种TM类似物:其中螺缩酮的侧链被除去但其立体化学被保留的TM 1,和其中TM 1的螺缩酮基序被其对映体形式取代的TM 2。我们已经观察到这些衍生物确实保留了对PP 1和PP 2A的相当大的抑制活性。通过使用PP 1的天然催化亚基(PP 1C)和PP 2A以及PP 1的重组γ同种型(PP 1 γ)的剂量抑制分析确定的PP 1/PP 2A比率对于TM 1在0.2-0.5范围内,对于TM 2在5-10范围内。由TM衍生为TM 1和TM 2引起的比率的显著增加表明螺缩酮的立体化学以及其侧链的存在是TM对PP 1和PP 2A的特征亲和力的重要因素。少

项目成果

期刊论文数量(32)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Takai, A., Tsuboi, K., Koyasu, M.& Isobe, M.: Biochemical Journal. 350. 81-88
高井,A.,坪井,K.,小安,M.
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Takai,A., Tsuboi,K., Koyasu,M. & Isobe,M.: "Effects of modification of the hydrophobic C1-C16 segment of tautomycin on its affinity to type 1 and type 2A protein phosphatases"Biochemical Journal. (印刷中).
Takai, A.、Tsuboi, K.、Koyasu, M. 和 Isobe, M.:“互变霉素疏水性 C1-C16 片段的修饰对其对 1 型和 2A 型蛋白磷酸酶亲和力的影响”《生化杂志》(印刷版)。 ) 期间)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

TAKAI Akira其他文献

TAKAI Akira的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('TAKAI Akira', 18)}}的其他基金

Development of real-time detection method of mRNA dynamics for the study of signal regulation system during left-right asymmetry formation
开发mRNA动态实时检测方法用于研究左右不对称形成过程中的信号调节系统
  • 批准号:
    25871128
  • 财政年份:
    2013
  • 资助金额:
    $ 8.38万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
Molecular entity of regulatory mechanism of muscarinergic receptor operated cation channel
毒蕈碱受体调控阳离子通道调控机制的分子实体
  • 批准号:
    24590266
  • 财政年份:
    2012
  • 资助金额:
    $ 8.38万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Search for the molecular entities of muscarine receptor-operated non-selective cation channels and their regulatory system
寻找毒蕈碱受体操纵的非选择性阳离子通道的分子实体及其调控系统
  • 批准号:
    19590202
  • 财政年份:
    2007
  • 资助金额:
    $ 8.38万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Molecular-biological approach to the regulatory mechanism of ciliary muscle contraction
睫状肌收缩调节机制的分子生物学方法
  • 批准号:
    13470365
  • 财政年份:
    2001
  • 资助金额:
    $ 8.38万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Intracellular distribution and regulatory function of protein phosphatases
蛋白磷酸酶的细胞内分布和调节功能
  • 批准号:
    09670042
  • 财政年份:
    1997
  • 资助金额:
    $ 8.38万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Survey of regulatory roles of protein dephosphorylation process in cell motility and trans-membrane ion movements
蛋白质去磷酸化过程在细胞运动和跨膜离子运动中的调节作用调查
  • 批准号:
    07670052
  • 财政年份:
    1995
  • 资助金额:
    $ 8.38万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Evaluation of the contribution of intracellular protein dephosphorylation process to regulation of the contractility of mammalian smooth muscle tissues'
细胞内蛋白质去磷酸化过程对调节哺乳动物平滑肌组织收缩性的贡献的评估
  • 批准号:
    04454136
  • 财政年份:
    1992
  • 资助金额:
    $ 8.38万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (B)
Studies on Physiological Roles of Protein Phosphatases in Mammalian Smooth Muscle Tissues
哺乳动物平滑肌组织中蛋白磷酸酶的生理作用研究
  • 批准号:
    01570062
  • 财政年份:
    1989
  • 资助金额:
    $ 8.38万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)

相似海外基金

Regulation of peroxisome biogenesis by protein phosphorylation and signal transduction
通过蛋白质磷酸化和信号转导调节过氧化物酶体生物合成
  • 批准号:
    26440032
  • 财政年份:
    2014
  • 资助金额:
    $ 8.38万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
SIGNAL TRANSDUCTION AND PROTEIN PHOSPHORYLATION SYMPOSIUM
信号转导与蛋白质磷酸化研讨会
  • 批准号:
    7955257
  • 财政年份:
    2009
  • 资助金额:
    $ 8.38万
  • 项目类别:
SIGNAL TRANSDUCTION AND PROTEIN PHOSPHORYLATION SYMPOSIUM
信号转导与蛋白质磷酸化研讨会
  • 批准号:
    7722364
  • 财政年份:
    2008
  • 资助金额:
    $ 8.38万
  • 项目类别:
SIGNAL TRANSDUCTION AND PROTEIN PHOSPHORYLATION SYMPOSIUM
信号转导与蛋白质磷酸化研讨会
  • 批准号:
    7601711
  • 财政年份:
    2007
  • 资助金额:
    $ 8.38万
  • 项目类别:
SIGNAL TRANSDUCTION AND PROTEIN PHOSPHORYLATION SYMPOSIUM
信号转导与蛋白质磷酸化研讨会
  • 批准号:
    7358727
  • 财政年份:
    2006
  • 资助金额:
    $ 8.38万
  • 项目类别:
The Role of Protein Phosphorylation and dephosphorylation in Neuronal Signal Transduction
蛋白质磷酸化和去磷酸化在神经信号转导中的作用
  • 批准号:
    02454137
  • 财政年份:
    1990
  • 资助金额:
    $ 8.38万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (B)
SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION
通过蛋白质磷酸化进行信号转导
  • 批准号:
    3224544
  • 财政年份:
    1978
  • 资助金额:
    $ 8.38万
  • 项目类别:
SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION
通过蛋白质磷酸化进行信号转导
  • 批准号:
    2135423
  • 财政年份:
    1978
  • 资助金额:
    $ 8.38万
  • 项目类别:
SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION
通过蛋白质磷酸化进行信号转导
  • 批准号:
    3224548
  • 财政年份:
    1978
  • 资助金额:
    $ 8.38万
  • 项目类别:
SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION
通过蛋白质磷酸化进行信号转导
  • 批准号:
    3224543
  • 财政年份:
    1978
  • 资助金额:
    $ 8.38万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了